Chronic Fatigue Researcher to Publish Book

Judy Mikovits, the controversial researcher who claimed to establish a link between chronic fatigue syndrome and a virus, has coauthored a book set to publish in May.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Microscopic image of XMRV (Xenotropic murine leukemia virus-related virus)WIKIMEDIA, CDCIn 2009, Judy Mikovits of the Whittemore Peterson Institute in Reno, Nevada, published a Science paper claiming that the majority of chronic fatigue patients she and her team examined (68 out of 101) carried xenotropic murine leukemia virus–related virus (XMRV). The researchers proposed XMRV as the cause of chronic fatigue syndrome (CFS). Two years later, Science retracted the paper without the full consent of Mikovits and her coauthors when follow-up studies failed to replicate the results indicated that laboratory contamination may have led to the findings. A veritable circus ensued with Mikovits being fired, sued, and arrested on charges were later dropped, all while she maintained her innocence and stuck by her claim that XMRV caused CFS. Now Mikovits has coauthored a book, Plague: One Scientist’s Intrepid Search for the Truth about Retroviruses, Chronic Fatigue Syndrome, Autism, and Other Diseases, detailing the ordeal, according to Retraction Watch.

Mikovits’s coauthor, Kent Heckenlively, drew the link from the XMRV-CFS story to the autism-vaccine conspiracy theory in a piece published Monday (March 10) on Age of Autism, a blog predicated on the premise that autism is a manmade affliction. “In many ways I felt her story, especially the campaign of persecution against her,” he wrote, “mirrored that of many other honest scientists who have looked for answers to the questions raised by these diseases.”

Heckenlively was referring to discredited autism researcher Andrew Wakefield, whose published claims that measles, mumps, rubella vaccinations caused autism were retracted from the literature and thoroughly debunked. Mikovits’s own follow-up research on the link between XMRV and CFS refuted her earlier findings. “The bottom line is we found no evidence of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies